Sources and References

Authority: Primary reference for blood type compatibility in the United States. The Red Cross is one of the largest blood collection organisations globally.

Used for: ABO and Rh compatibility matrices; US blood type distribution by ethnicity; O-negative universal donor information; donation eligibility and frequency.

Authority: Top-ranked US academic medical centre. Medical content reviewed by board-certified physicians.

Used for: Anti-D immunoglobulin dosing schedule; Rh sensitisation incidence statistics before and after prophylaxis; general blood type educational content.

Authority: Professional society of haematologists. Education content aimed at patients and healthcare professionals.

Used for: Blood typing and cross-matching procedures; compatibility principles; haemolytic transfusion reaction description.

Authority: UNOS administers the US national organ transplant waiting list under federal contract from HRSA.

Used for: Organ allocation algorithm description; ABO compatibility requirements for solid organ transplant; US transplant waiting list data.

Authority: Patient and professional educational organisation focused on kidney disease and transplantation.

Used for: Kidney transplant blood type compatibility; living donor paired kidney exchange explanation; statistics on paired exchange volumes.

Authority: Academic blood centre affiliated with Stanford University Medical Center.

Used for: US blood type distribution percentages; global blood type frequency estimates.

Authority: Consumer health information service maintained by the National Library of Medicine (NLM), part of the US National Institutes of Health (NIH).

Used for: General blood type and Rh factor educational reference.

Authority: Major academic medical centre and research hospital, consistently ranked in top US hospitals.

Used for: Blood typing procedure description; clinical context.

Authority: UK national health service. Content reviewed by NHS clinical editors.

Used for: UK anti-D prophylaxis protocol; NHS blood group educational content.

Authority: One of the largest non-profit blood suppliers in the United States.

Used for: O-negative donor recruitment and supply data; plasma donation information.

Franchini M, Lippi G. (2010). The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer. A review of the literature. Thrombosis Research, 125(3), 215-218.

Used for: Blood group O and thromboembolism risk associations referenced in per-type clinical notes.

Whitaker BI, et al. (2017). The 2017 National Blood Collection and Utilization Survey Report. US Department of Health and Human Services.

Used for: US blood supply statistics.

Bowman JM. (1998). RhD hemolytic disease of the newborn. New England Journal of Medicine, 339(24), 1775-1777.

Used for: Historical pre-prophylaxis HDN incidence rates.

Kochhar PK, Bhirangi K. (2012). Rh incompatibility. Indian Journal of Pediatrics, 79(10), 1349-1354.

Used for: Rh incompatibility and anti-D prophylaxis effectiveness data.

Westhoff CM. (2019). Blood group genotyping. Blood, 133(17), 1814-1820.

Used for: Blood group genetics, including rare phenotype discussion (Rhnull, Bombay).